For the quarter ending 2025-09-30, TGEN had $13,613,111 increase in cash & cash equivalents over the period. -$3,636,106 in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Consolidated net loss | -2,119,066 | -2,133,644 |
| Depreciation and amortization | 230,149 | 391,381 |
| Provision for (recovery of) credit losses | 24,117 | -75,000 |
| Stock-based compensation | 126,419 | 83,439 |
| Unrealized loss on investment securities | -56,246 | -18,749 |
| (gain) loss on disposition of assets | -1,713 | 280 |
| Non-cash interest expense | 9,938 | 33,538 |
| Accounts receivable | -395,925 | 538,938 |
| Inventory | -121,145 | 45,224 |
| Unbilled revenue | 0 | 272,160 |
| Prepaid assets and other current assets | -30,421 | 268,691 |
| Other assets | -144,038 | -186,766 |
| Accounts payable | -1,528,926 | 803,540 |
| Accrued expenses and other current liabilities | 11,573 | 85,325 |
| Deferred revenue | -790,669 | -2,193,607 |
| Other liabilities | -273,822 | -395,134 |
| Net cash used in operating activities | -3,560,799 | -3,775,620 |
| Purchases of property and equipment | 75,307 | 277,989 |
| Proceeds from disposition of assets | 1,000 | 280 |
| Distributions to non-controlling interest | 0 | 42,956 |
| Net cash used in investing activities | -74,307 | -320,665 |
| Proceeds from follow on offering, net of transaction costs | 18,105,100 | - |
| Proceeds from related party notes payable | 0 | - |
| Related-party note repayment | 1,076,956 | - |
| Finance lease principal payments | 43,404 | 63,010 |
| Proceeds from the exercise of stock options | 263,477 | 394,926 |
| Net cash provided by financing activities | 17,248,217 | 331,916 |
| Net increase (decrease) in cash and cash equivalents | 13,613,111 | -3,764,369 |
| Cash and cash equivalents at beginning of period | 5,405,233 | - |
| Cash and cash equivalents at end of period | 15,253,975 | - |
TECOGEN INC. (TGEN)
TECOGEN INC. (TGEN)